Cart
sales@molnova.com
Chonglou Saponin VII
CAS No. 68124-04-9
Chonglou Saponin VII( —— )
Catalog No. M18991 CAS No. 68124-04-9
Chonglou saponin VII shows inhibitory effects on cell proliferation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 104 | In Stock |
|
| 10MG | 180 | In Stock |
|
| 25MG | 303 | In Stock |
|
| 50MG | 442 | In Stock |
|
| 100MG | 634 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameChonglou Saponin VII
-
NoteResearch use only, not for human use.
-
Brief DescriptionChonglou saponin VII shows inhibitory effects on cell proliferation.
-
DescriptionChonglou saponin VII shows inhibitory effects on cell proliferation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number68124-04-9
-
Formula Weight1031.2
-
Molecular FormulaC51H82O21
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (96.98 mM)
-
SMILES[C@@H]1([C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@H]1[C@@H](O[C@H]([C@@H]([C@@H]1O)O)O[C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@@]6([C@H]([C@@]5([C@]4(CC[C@@H]3[C@]2(CC1)C)C)O)C)CC[C@H](CO6)C)CO)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. CAO, Heng-tao, et al. Analysis of four saponins in Rhizoma Paridis with substitution method of reference substance. Chinese Journal of Pharmaceutical Analysis,2011,31(9):1641-5.
molnova catalog
related products
-
Foxy-5
Foxy-5 is a novel Wnt-5A mimicking hexapeptide that inhibits breast cancer metastasis in vivo by targeting cell motility.
-
K-756
K-756 is a direct and selective inhibitor of tankyrase (TNKS), which inhibits the ADP-ribosylation activity of TNKS1 (IC50 = 31 nM) and TNKS2 (IC50 = 36 nM).
-
WWL70
WWL70 is a selective alpha/beta hydrolase domain 6 inhibitors (IC50: 70 nM). WWL70 (10 μM, 1 h) treatment, 2-Arachidonoylglycerol is increased by 20% compared to untreated cells.
